Table 3.
Index | group | First Period | Second Period | ||||
---|---|---|---|---|---|---|---|
N | Mean | SD | N | Mean | SD | ||
Orientation | Aa | 19 | 0.26 | 0.56 | 17 | 0.00 | 0.00 |
B | 20 | 0.10 | 0.31 | 20 | 0.25 | 0.72 | |
P-value | 0.550 | 0.442 | |||||
Immediate memory | Aa | 19 | 0.05 | 0.23 | 17 | 0.00 | 0.00 |
B | 20 | 0.10 | 0.31 | 20 | 0.05 | 0.22 | |
P-value | 0.813 | 0.798 | |||||
Concentration and calculation | Aa | 19 | 0.47 | 0.70 | 17 | 0.00 | 0.50 |
B | 20 | 0.00 | 0.32 | 20 | 0.30 | 0.47 | |
P-value | 0.057 | 0.177 | |||||
Remembrance | Aa | 19 | 0.32 | 0.48 | 17 | 0.06 | 0.24 |
B | 20 | 0.00 | 0.32 | 20 | 0.20 | 0.41 | |
P-value | 0.113 | 0.478 | |||||
Language and understanding | Aa | 19 | 0.21 | 0.53 | 17 | 0.06 | 0.43 |
B | 20 | 0.15 | 0.37 | 20 | 0.15 | 0.37 | |
P-value | 0.728 | 0.684 | |||||
Space situation | Aa | 19 | 0.00 | 0.00 | 17 | 0.00 | 0.00 |
B | 20 | 0.00 | 0.00 | 20 | 0.05 | 0.22 | |
P-value | 1.00 | 0.798 | |||||
Cognitive impairment (general) | Aa | 19 | 1.32 | 1.38 | 17 | 0.12 | 0.78 |
B | 20 | 0.35 | 0.81 | 20 | 1.00 | 1.17 | |
P-value | 0.028 | 0.030 |
aThe group A took valerian capsules in the first therapeutic period of one month and placebo in the second therapeutic period of one month, and vice versa in group B